IPSEN BIOPHARMACEUTICALS, INC.

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

108

Firms Hired

Active Period

2016–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	9	3
2025	—	14	4
2024	—	14	4
2023	—	12	3
2022	—	14	4
2021	—	12	3
2020	—	8	2
2019	—	8	2
2018	—	8	2
2017	—	4	2
2016	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
W STRATEGIES, LLC	—	38
AMERICAN CAPITOL GROUP	—	20
CAPITOL COUNSEL LLC	—	18
RICCHETTI INCORPORATED	—	18
HOLLAND & KNIGHT LLP	—	9
ARNOLD & PORTER KAYE SCHOLER LLP	—	5

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	83
SENATE	62
Natl Economic Council (NEC)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medicare/Medicaid	Medicare/Medicaid	77
Health Issues	Health Issues	45
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	21
Pharmacy	Pharmacy	18
Budget/Appropriations	Budget/Appropriations	3
Veterans	Veterans	1
Immigration	Immigration	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 842119th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2025 · second_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R.842

S. 339119th Congress

A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.

2025 · second_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: S.339

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · second_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R.1

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2025 · first_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R.5376

Show 21 more cited filings

H.R. 842119th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2025 · first_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R.842

S. 339119th Congress

A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.

2025 · first_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: S.339

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2024 · fourth_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R.5376

H.R. 2407118th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · fourth_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R. 2407

H.R. 3916118th Congress

SCREENS for Cancer Act of 2024

2024 · fourth_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R. 3916

S. 1840118th Congress

SCREENS for Cancer Act of 2023

2024 · fourth_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: S. 1840

S. 2085118th Congress

Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · fourth_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: S. 2085

H.R. 2407118th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · third_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R. 2407

H.R. 3916118th Congress

SCREENS for Cancer Act of 2024

2024 · third_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R. 3916

S. 1840118th Congress

SCREENS for Cancer Act of 2023

2024 · third_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: S. 1840

S. 2085118th Congress

Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · third_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: S. 2085

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2024 · third_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2024 · second_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R.5376

H.R. 2407118th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · second_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R. 2407

H.R. 3916118th Congress

SCREENS for Cancer Act of 2024

2024 · second_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R. 3916

S. 1840118th Congress

SCREENS for Cancer Act of 2023

2024 · second_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: S. 1840

S. 2085118th Congress

Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · second_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: S. 2085

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2024 · first_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R.5376

H.R. 2407118th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · first_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R. 2407

H.R. 3916118th Congress

SCREENS for Cancer Act of 2024

2024 · first_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: H.R. 3916

S. 1840118th Congress

SCREENS for Cancer Act of 2023

2024 · first_quarter · Firm: RICCHETTI INCORPORATED

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $20,000

Matched citations: S. 1840

Source: Senate LDA

IPSEN BIOPHARMACEUTICALS, INC. — Lobbying Disclosure | Poliscope